Telehealth Peptide Programs: A Publisher's Evaluation Checklist
Telehealth Peptide Programs: A Publisher's Evaluation Checklist
A telehealth peptide program is worth promoting only if it's a licensed clinical service, its clinicians are licensed where it enrolls patients, a licensed pharmacy dispenses, every substance it offers is FDA-approved or currently eligible to be compounded, and its claims and affiliate terms hold up. If any of these fails, don't promote it.
Peptide programs are growing fast, and the line between a legitimate clinic and a research-chemical seller isn't always obvious from a homepage. Use this checklist before you send a single click.
Confirm it is a licensed clinical service
- Patients complete an intake and are evaluated by a licensed clinician.
- The clinician can decline treatment.
- Prescriptions are issued only when appropriate.
- Nothing is sold without a prescription, and nothing is labeled "research use only."
Verify clinicians and licensed states
- The provider company and clinical group are named on the site.
- Ask for the list of states where clinicians are licensed and the program enrolls patients.
- Confirm traffic outside those states won't be accepted.
Identify the dispensing pharmacy
- Which pharmacy fills prescriptions, and where it's licensed.
- Whether it's a 503A compounding pharmacy, a 503B outsourcing facility or a retail pharmacy.
- Whether medications are described accurately, including when they're compounded.
Check the legal status of every substance offered
Regulation moved twice in 2026. In April, FDA removed 12 peptides from Category 2 of its 503A bulks list, but that didn't make them eligible to compound. In July, an FDA advisory committee recommended adding six peptides to the list, but FDA must still complete rulemaking. None of those peptides is an FDA-approved drug. See our 2026 regulation update.
Ask the advertiser to show, for each substance it offers, that it's either FDA-approved or currently eligible to be compounded. If it can't, don't promote that offer.
Review claims, creative and affiliate terms
Do
- Clinician-led, approved wording
- Dated, sourced statements about regulatory status
- Clear pricing, renewal and cancellation terms
Avoid
- Healing, injury recovery, anti-aging, muscle or performance claims
- Describing an advisory vote as FDA approval
- Dosing, "stacks" or reconstitution instructions
Complete the program checklist
- Licensed clinician evaluates every patient and can decline
- No product sold without a prescription; nothing labeled research use only
- Provider, clinical group and licensed states identified
- Dispensing pharmacy identified and licensed for what it dispenses
- Every substance is FDA-approved or currently eligible to compound
- Approved claims avoid healing, anti-aging and performance promises
- Pricing, renewal and cancellation clear
- Payable event, reversals and traffic rules documented
Clinician involvement alone doesn't make a substance lawful to prescribe or compound. Review every named substance individually against current official sources, and check the peptide status board for where the rules stand.
Frequently asked questions
What makes a peptide program legitimate?
A licensed clinician evaluates each patient, a licensed pharmacy dispenses, and every substance offered is FDA-approved or currently eligible to be compounded. Nothing is sold as "research use only."
How do I check whether a peptide can be legally compounded?
Ask the advertiser for documentation, and check FDA's 503A bulk drug substances lists and announcements. Removal from Category 2 alone doesn't make a peptide eligible.
What are red flags in peptide offers?
"Research use only" labels, products sold without a prescription, vials or bacteriostatic water bundled for sale, dosing calculators, and healing or anti-aging promises.
Practical guides and programs for health and beauty publishers.
Educational content for marketers and publishers, not medical, legal or financial advice. Examples labeled hypothetical are illustrations, not results. MarketHealth may earn revenue from programs it describes. See our affiliate disclosure and editorial policy.
Keep reading
Related guides
Are Peptides Legal? Approved, Compounded and Research-Use-Only Explained
Understand the difference between FDA-approved, compounded and research-use-only peptides, and what each status means for affiliate publishers.
Read guideTelehealth Peptide Content: A Claims Review Guide
Review telehealth peptide affiliate content before publishing: prohibited claims, required disclosures, regulatory-status wording and sources.
Read guide
GLP-1 Telehealth Affiliate Programs: Evaluation Checklist
Evaluate GLP-1 telehealth affiliate programs by provider scope, markets, eligibility, approved claims and payout terms, with a practical review checklist.
Read guide